Avitide's Series E - II Round

Avitide raised a round of funding on January 02, 2018.

Avitide delivers on-demand, molecule-specific biopharmaceutical affinity purification solutions with an industry-leading 3-month service. Avitide's affinity separation technology enables its partners …

Articles about Avitide's Series E - II Round: